We report an 82-year-old man who developed ventricular tachycardia and Torsades de Pointes (TdP) after oral administration of garenoxacin, a novel quinolone antibiotic agent that differs from the third-generation quinolones, for pneumonia.
Torsades de Pointes
garenoxacin
TdP
garenoxacin
ventricular tachycardia
garenoxacin